The Impact of Effective Patient Advocacy in Ghana Health Care Reform

AbstractPatient advocacy has become a vital concept for healthcare providers all over the world. There is evidence that the concept of patient advocacy is not new in Ghana. However, the degree of its practice continues to be negative and quite narrow in Ghana and even in Africa as a whole. It has also been argued that effective patience advocacy practice is either scarce or non-existent in Ghana. To address this issue, an assessment of the medical policies in Ghana was conducted, informed by the applied psychology theoretical framework. This study focused on using phenomenological inquiry to better understand patients’ experiences within Ghana healthcare facilities to allow for the determination of the impact of patient advocacy in Ghana. The study used purposive sampling for the selection of the participants. Questionnaires were designed after the form of semi-structured interview style to stimulate responses. In all, data was collected from 23 participants from four most highly populated urban regions in Ghana. The study revealed 11 lapses and shortcomings in the practice of patient advocacy in Ghana. Patients were found to be either unaware of their rights or felt less empowered to participate in their care giving. Healthcare professionals, on the other hand, need periodical training to instruct them in their ethical duty as patient advocates. The systemic poor interaction between patients and care givers was also found to act adversely against the practice of patient advocacy in Ghana. Therefore, there is the need for a multi-prong new policy and structural model that essentially puts patients right and inclusion and the ethics of healthcare professionals at the forefront resulting in positive social change

Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets

<p>Abstract</p> <p>Background</p> <p>Effective case management is central to reducing malaria mortality and morbidity worldwide, but only a minority of those affected by malaria, have access to prompt effective treatment.</p> <p>In Kenya, the Division of Malaria Control is committed to ensuring that 80 percent of childhood fevers are treated with effective anti-malarial medicines within 24 hours of fever onset, but this target is largely unmet. This review aimed to document evidence on access to effective malaria treatment in Kenya, identify factors that influence access, and make recommendations on how to improve prompt access to effective malaria treatment. Since treatment-seeking patterns for malaria are similar in many settings in sub-Saharan Africa, the findings presented in this review have important lessons for other malaria endemic countries.</p> <p>Methods</p> <p>Internet searches were conducted in PUBMED (MEDLINE) and HINARI databases using specific search terms and strategies. Grey literature was obtained by soliciting reports from individual researchers working in the treatment-seeking field, from websites of major organizations involved in malaria control and from international reports.</p> <p>Results</p> <p>The review indicated that malaria treatment-seeking occurs mostly in the informal sector; that most fevers are treated, but treatment is often ineffective. Irrational drug use was identified as a problem in most studies, but determinants of this behaviour were not documented. Availability of non-recommended medicines over-the-counter and the presence of substandard anti-malarials in the market are well documented. Demand side determinants of access include perception of illness causes, severity and timing of treatment, perceptions of treatment efficacy, simplicity of regimens and ability to pay. Supply side determinants include distance to health facilities, availability of medicines, prescribing and dispensing practices and quality of medicines. Policy level factors are around the complexity and unclear messages regarding drug policy changes.</p> <p>Conclusion</p> <p>Kenya, like many other African countries, is still far from achieving the Abuja targets. The government, with support from donors, should invest adequately in mechanisms that promote access to effective treatment. Such approaches should focus on factors influencing multiple dimensions of access and will require the cooperation of all stakeholders working in malaria control.</p